Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yeastern Biotech is a Taiwan-based private biotechnology company focused on life science research tools, molecular biology reagents, and selected diagnostic products. Its core business centers on commercially marketed products such as chemically competent cells, cloning vectors, protein expression systems, PCR/qPCR/RT-PCR reagents, and DNA/RNA extraction kits. The company highlights its ECOS competent cells as a flagship product line and also offers OEM and ODM services for research-use and biomedical customers. Yeastern Biotech appears to operate as a commercial life science tools supplier rather than a therapeutics developer, with capabilities spanning reagent development, assay-related products, and manufacturing under quality systems including ISO 13485 and GMP.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yeastern Biotech.